Resistance-induced hyperinsulinemia can also stimulate the production of insulin-like growth factor 1 (IGF-1) [84], which may promote endometrial cell proliferation and increase the risk of endometrial cancer. The gene discussed is IGF1; the disease is Hyperinsulinemia.